Eric Lefkofsky – Entrepreneur – Philanthropist – Champion Of Cancer Research

spcblog, 05 June 2018, No comments
Categories: Cancer, Doctor

There are a number of companies around the world making an impact in the world of cancer care. Tempus is one such company. The company is presently building a library, the world’s largest, which will house clinical and molecular data. Its operating system will make that data accessible to help enable physicians to offer advanced and personalized cancer care and treatments for patients.

The company is able to aggregate an immense amount of mental records, images, and radiology scans that will help doctors arrive at therapeutic and phenotypic results for patients. Eric Lefkofsky is an astute business man and entrepreneur. He is a co-founder of Tempus and a founding partner of Lightbank. His Tempus team is highly qualified and includes several medical doctors, a well-connected president, engineer, and senior director of clinical lab operations.

Personalized data is a critical key to more precise and personalized patient care. The mission of Tempus is to place patient’s molecular clinical data in one location. Physicians can save time and lives by making decision in real-time. This means their decisions will be driven by critical data right at their fingertips. Through the analysis of millions of cancer patients, and the aggregation of their clinical data, doctors can draw from a wealth of information.

Chicago based Tempus Labs was founded in 2015. Tempus also adds molecular data through a system of sequencing DNA and RNA. Data pipelines will also be put in place to cleanse, collect, and analyze molecular and clinical information. Lefkofsky wears a lot of professional hats. For Lurie Children’s Hospital, he serves as a Trustee. He also volunteers time for the Art Institute of Chicago, World Business Chicago, and the Museum of Science and Industry. Michigan Law School awarded him a Juris Doctor, and he received his degree from the University of Michigan.

To Read More Click Here


Leave a Reply:

Name *

Mail (hidden) *